MENU

ANVS Annovis Bio Forecast, Technical & Fundamental Analysis

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology
ANVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ANVS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANVS is expected to report earnings to rise 4.57% to -46 cents per share on November 06

Annovis Bio ANVS Stock Earnings Reports
Q3'24
Est.
$-0.46
Q2'24
Beat
by $0.19
Q1'24
Beat
by $0.10
Q4'23
Missed
by $0.83
Q3'23
Missed
by $0.54
The last earnings report on August 15 showed earnings per share of -43 cents, beating the estimate of -62 cents. With 111.99K shares outstanding, the current market capitalization sits at 105.74M.
A.I. Advisor
published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ANVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-1.06%
ADXN - ANVS
36%
Loosely correlated
+5.71%
EWTX - ANVS
33%
Poorly correlated
-4.64%
TNYA - ANVS
29%
Poorly correlated
-5.60%
ZVSA - ANVS
26%
Poorly correlated
-2.90%
ATXI - ANVS
26%
Poorly correlated
+9.84%
More